Skip to content

Ardelyx ARDX Licensing revenue — Payment

Similar metrics at other companies

BioCryst Pharmaceuticals logo
BCRXLicense and other revenues — Receivables
$3.98M+78.9%
BlackBerry logo
BBLicensing — Revenue
$7M+48.9%
SoundHound AI, Inc. logo
SOUNLicensing — Revenue
$7.68M+101%
Stoke Therapeutics, Inc. logo
STOKLicense — Revenue
$2.88M-60.9%
Supernus Pharmaceuticals logo
SUPNLicense — Revenue recognized
$20M+433%
Anterix logo
ATEXLicense — Prepayments received
$13M

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+25.5%
Enterprise value$1.71B+27.1%
P/S3.6×+0.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's licensing revenue — payment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's licensing revenue — payment?
Ardelyx (ARDX) reported licensing revenue — payment of $15M in Q1 2026.
What does licensing revenue — payment mean?
This metric captures the cash or recognized revenue inflows derived from licensing contracts, including upfront fees or periodic payments. It serves as a key indicator of the immediate financial value generated by the company's strategic collaborations. Tracking this helps assess the liquidity and cash-generating capacity of the licensing segment.